ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå ±Ô¸ð : Áø´Ü °Ë»çº°, ¿¬·É´ëº°, ÃÖÁ¾»ç¿ëÀÚº° - Áö¿ªº° Àü¸Á, °æÀï Àü·«, ºÎ¹®º° ¿¹Ãø(-2033³â)
Cervical Cancer Diagnostic Market Size- By Diagnostic Test, By Age Group, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
»óǰÄÚµå : 1482313
¸®¼­Ä¡»ç : SPER Market Research Pvt. Ltd.
¹ßÇàÀÏ : 2024³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 205 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 6,031,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç ÀÎ¿ë ½Ã¿¡´Â Ãâó¸¦ ¸í½ÃÇØ Áֽñ⠹ٶø´Ï´Ù
US $ 5,650 £Ü 8,017,000
PDF (Group License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 5ȸ±îÁö °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. ÀÎ¿ë ½Ã¿¡´Â Ãâó¸¦ ¸í½ÃÇØ Áֽñ⠹ٶø´Ï´Ù.
US $ 7,450 £Ü 10,572,000
PDF (Company License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. ÀÎ¿ë ½Ã¿¡´Â Ãâó¸¦ ¸í½ÃÇØ Áֽñ⠹ٶø´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå ±Ô¸ð´Â 2033³â±îÁö 5.28%ÀÇ CAGRÀ» ±â·ÏÇϸç 133¾ï 7,000¸¸ ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

2020³â COVID-19´Â ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆ°í, ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀåµµ ÀÇ·á ¼­ºñ½º Áß´ÜÀ¸·Î ÀÎÇØ ¾î·Á¿òÀ» °Þ¾ú½À´Ï´Ù. COVID-19 »ç·Ê °ü¸®¿¡ ÁýÁßÇÑ °á°ú ÀڱðæºÎ¾Ï Áø´Ü °Ç¼ö°¡ °¨¼ÒÇϰí, ¸¹Àº ÀÇ·á±â°üÀÌ ±ä±ÞÇÏÁö ¾ÊÀº ¼ö¼ú°ú °ËÁøÀ» Áö¿¬½ÃÅ´¿¡ µû¶ó Á¤±â °ËÁøÀ» ¹Þ´Â ¿©¼ºÀÇ ¼ö¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

¼¼°è ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÁ¤ ¹× ¿¹Ãø, °¢ ºÎ¹®º°¡¤Áö¿ªº°¡¤ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï »óȲ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

Á¦5Àå ½ÃÀå º¯¼ö¿Í Àü¸Á

Á¦6Àå °æÀï »óȲ

Á¦7Àå ¼¼°èÀÇ ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå : Áø´Ü °Ë»çº°

Á¦8Àå ¼¼°èÀÇ ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå : ¿¬·ÉÃþº°

Á¦9Àå ¼¼°èÀÇ ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ¼¼°èÀÇ ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå ¿¹Ãø

Á¦11Àå ¼¼°èÀÇ ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå : Áö¿ªº°

Á¦12Àå ±â¾÷ °³¿ä

Á¦13Àå ¾à¾î ¸®½ºÆ®

Á¦14Àå Âü°í ¸µÅ©

Á¦15Àå °á·Ð

Á¦16Àå Á¶»ç ¹üÀ§

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Cervical Cancer Diagnostic Market Introduction and Overview

According to SPER market research, 'Cervical Cancer Diagnostic Market Size- By Diagnostic Test, Age Group, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Cervical Cancer Diagnostic Market is predicted to reach 13.37 billion by 2033 with a CAGR of 5.28%.

Cervical cancer is a type of cancer that originates in the cervix. The thinner, lower end of the uterus is known as the cervix (womb). The uterus and vagina are connected via the cervix. Typically, it develops gradually over time. Dysplasia occurs in the cells of the cervix before cervical cancer develops. It begins to reveal aberrant cells in the cervical tissue. If the abnormal cells are not cleared or killed, they may eventually grow into malignant cells that proliferate and spread throughout the cervix and surrounding tissues.

The 2020 COVID-19 pandemic had a significant impact on the market. Cervical cancer diagnostics market faced challenges because to the COVID-19 pandemic-related disruptions in healthcare services. Cervical cancer diagnostics decreased as a result of the focus on COVID-19 case management. A significant number of healthcare facilities delayed non-urgent surgeries and screenings, which in turn affected the number of women receiving routine testing.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Diagnostic Test, By Age Group, By End User

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Zilico, Siemens Healthineers AG, QIAGEN NV, Abbott Laboratories, Becton, Dickinson and Co, Quest Diagnostics Inc, F. Hoffmann-La Roche Ltd, Guided Therapeutics, Hologic Inc, Bio-Rad Laboratories.

Global Cervical Cancer Diagnostic Market Segmentation:

By Diagnostic Test: Based on the Diagnostic Test, Global Cervical Cancer Diagnostic Market is segmented as, Pap Smear Tests, HPV Test, Biopsy and ECC, Colposcopy Tests, Others.

By End User: Based on the End User, Global Cervical Cancer Diagnostic Market is segmented as; Hospitals, Speciality Clinics, Cancer and Radiation Therapy Centers, Diagnostic Centers, Others.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

5. Market variable and outlook

6. Competitive Landscape

7. Global Cervical Cancer Diagnostic Market, By Diagnostic Test (USD Million) 2020-2033

8. Global Cervical Cancer Diagnostic Market, By Age Group (USD Million) 2020-2033

9. Global Cervical Cancer Diagnostic Market, By End User (USD Million) 2020-2033

10. Global Cervical Cancer Diagnostic Market Forecast, 2020-2033 (USD Million)

11. Global Cervical Cancer Diagnostic Market, By Region, 2020-2033 (USD Million)

12. Company Profile

13. List of Abbreviations

14. Reference Links

15. Conclusion

16. Research Scope

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â